Showing results (261-270 of 613) with videos related to

Sort By:
Pageof 62
The Journal of Urology|June 11, 2005
Fibrin glue v sutured bolster: lessons learned during 100 laparoscopic partial nephrectomiesWilliam K Johnston, Jeffrey S Montgomery, Brian D Seifman, et al.
The Journal of Urology|August 8, 2006
Cost trends for oncological renal surgery: support for a laparoscopic standard of careJohn M Hollingsworth, David C Miller, Rodney L Dunn, et al.
Open Access Journal of Urology|November 8, 2013
Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillanceJaclyn C Milose, Christopher P Filson, Alon Z Weizer, et al.
British Journal of Pain|March 28, 2024
Treated versus self-reported prevalence of chronic pain and costs of patients' health services utilization: a population-based study of health administrative databasesNguyen Xuan Thanh, Elena Lopatina, Lori S Montgomery, et al.
Dakar Medical|December 19, 2003
[Fibrinolytic syndrome during surgery for benign prostatic hypertrophy (50 cases in the urology service at the Aristide le Dantec University Hospital Center)]D Thiam, M Ba, A O Toure Fall, et al.
Dakar Medical|April 18, 2002
[Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal]T N Dieye, O Ndiaye, A B Ndiaye, et al.
The Prostate|July 11, 2008
No association between a polymorphic variant of the IRS-1 gene and prostate cancer riskK Fall, J R Stark, L A Mucci, et al.
International Journal of General Medicine|May 23, 2012
Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisonsHaya Ascher-Svanum, William S Montgomery, David P McDonnell, et al.
Mycologia|April 9, 2016
Geographic variation in mycangial communities of Xyleborus glabratusAlina S Campbell, Randy C Ploetz, Tyler J Dreaden, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 1994
Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in miceC T Culiat, L J Stubbs, C S Montgomery, et al.
Pageof 62